ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
DoctorBrad
|
232 |
51K |
19 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
51K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
DoctorBrad
|
232 |
51K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
232
|
51K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Oncolytic Virotherapy CF33 Patent Granted in China
|
|
DoctorBrad
|
118 |
55K |
5 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
118
|
55K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
DoctorBrad
|
62 |
16K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
16K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
DoctorBrad
|
196 |
36K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DoctorBrad
|
1.2K |
297K |
3 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
1.2K
|
297K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
DoctorBrad
|
626 |
196K |
10 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
626
|
196K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DoctorBrad
|
1.2K |
297K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.2K
|
297K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DoctorBrad
|
1.2K |
297K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.2K
|
297K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
DoctorBrad
|
152 |
45K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
45K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
DoctorBrad
|
111 |
33K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
111
|
33K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
DoctorBrad
|
209 |
49K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
49K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Presentation - Phase 1 Top-Line Results
|
|
DoctorBrad
|
34 |
10K |
24 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
34
|
10K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
DoctorBrad
|
152 |
45K |
18 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
45K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
DoctorBrad
|
152 |
45K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
45K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
DoctorBrad
|
114 |
32K |
30 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
114
|
32K
|
30
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
DoctorBrad
|
1.2K |
297K |
24 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
1.2K
|
297K
|
24
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
DoctorBrad
|
423 |
146K |
16 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
423
|
146K
|
16
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
DoctorBrad
|
423 |
146K |
20 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
423
|
146K
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
DoctorBrad
|
264 |
98K |
9 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
264
|
98K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Results show MPL suppresses biomarkers associated with MND
|
|
DoctorBrad
|
200 |
41K |
25 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
200
|
41K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
DoctorBrad
|
396 |
82K |
32 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
32
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
DoctorBrad
|
85 |
19K |
3 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
85
|
19K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
DoctorBrad
|
61 |
13K |
11 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
61
|
13K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
|
|
DoctorBrad
|
327 |
151K |
1 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
327
|
151K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
DoctorBrad
|
439 |
227K |
2 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
439
|
227K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
DoctorBrad
|
439 |
227K |
1 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
439
|
227K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
DoctorBrad
|
439 |
227K |
3 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
439
|
227K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
DoctorBrad
|
425 |
123K |
1 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
123K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Richard Mollard
|
|
DoctorBrad
|
46 |
11K |
8 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
46
|
11K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
DoctorBrad
|
22K |
11M |
0 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
22K
|
11M
|
0
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
DoctorBrad
|
31K |
15M |
21 |
04/05/22 |
04/05/22 |
Charts
|
31K
|
15M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
DoctorBrad
|
407 |
164K |
1 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
407
|
164K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
DoctorBrad
|
448 |
251K |
9 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
448
|
251K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 Shareholders as at 30 April 2022 - With Variations
|
|
DoctorBrad
|
34 |
8.6K |
4 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
34
|
8.6K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
DoctorBrad
|
22K |
11M |
13 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
22K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
DoctorBrad
|
22K |
11M |
3 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
22K
|
11M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
DoctorBrad
|
154 |
74K |
1 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
154
|
74K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Science Series CHECKvacc
|
|
DoctorBrad
|
154 |
74K |
8 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
154
|
74K
|
8
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Prospectus
|
|
DoctorBrad
|
2 |
1.3K |
7 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
2
|
1.3K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
DoctorBrad
|
22K |
11M |
11 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
22K
|
11M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL FOR THE PHASE 2 CLINICAL TRIAL OF HER-VAXX
|
|
DoctorBrad
|
167 |
87K |
0 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
167
|
87K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene HER-Vaxx Immunotherapy Patent Allowed in China
|
|
DoctorBrad
|
161 |
87K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
161
|
87K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Partnership with Carepath for in-home COPD monitoring
|
|
DoctorBrad
|
36 |
9.6K |
4 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
36
|
9.6K
|
4
|
|
ASX - By Stock
|
FL1 |
Re:
Ann: Notification of buy-back - OOK
|
|
DoctorBrad
|
8 |
3.6K |
3 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
8
|
3.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine phase 2b cancer trial expands to New Zealand
|
|
DoctorBrad
|
32 |
7.2K |
5 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
32
|
7.2K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Announcement, within the next 48hrs
|
|
DoctorBrad
|
31 |
9.5K |
5 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
31
|
9.5K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron planned Acquisition of R&D Vaccine Company
|
|
DoctorBrad
|
115 |
32K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
115
|
32K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Immuron planned Acquisition of R&D Vaccine Company
|
|
DoctorBrad
|
115 |
32K |
5 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
115
|
32K
|
5
|
|
ASX - By Stock
|
FL1 |
Re:
Ann: 2021 Annual Report to Shareholders
|
|
DoctorBrad
|
36 |
10K |
1 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
36
|
10K
|
1
|
|